» Articles » PMID: 38282942

Epidemiology and Risk Factors for Rheumatoid Arthritis Development

Overview
Specialty Rheumatology
Date 2024 Jan 29
PMID 38282942
Authors
Affiliations
Soon will be listed here.
Abstract

Rheumatoid arthritis (RA) is a prevalent chronic inflammatory arthritis worldwide, significantly impacting patients and population health. The disease affects women primarily, with a female-to-male ratio of three to one. Its pathogenesis is multifactorial, including genetic and environmental risk factors. Epidemiological studies highlight the link between the environment and genetic susceptibility to RA. The so-called shared epitope is the most significant risk factor that seems to act synergetic with other environmental factors in the disease occurrence. In addition, recent findings suggest a potential role of new substantial environmental factors, such as the observed pollution of the planet's natural resources, on the susceptibility and progression of the disease. This review summarises the most decisive evidence on epidemiology and genetic, environmental, and lifestyle risk factors for RA. It shows that studying genetic and environmental factors in correlation could lead to prevention strategies that may impact the natural history of the disease.

Citing Articles

Time-restricted feeding alleviates arthritis symptoms augmented by high-fat diet.

Bur Z, Vendl B, Sudy A, Lumniczky Z, Szanto C, Mocsai A Front Immunol. 2025; 16:1512328.

PMID: 40018036 PMC: 11864949. DOI: 10.3389/fimmu.2025.1512328.


A comparative assessment of rheumatoid arthritis burden: trends in China, the US, India, Europe, and globally from 1990 to 2021 and forecasts to 2030 utilizing GBD data.

Yang Y, Ning X, Zhou L, Xie L, Zhang X, Yu L Z Rheumatol. 2025; .

PMID: 40014093 DOI: 10.1007/s00393-025-01628-w.


Integrative analysis of lncRNAs in rheumatoid arthritis: from bioinformatics to experimental validation.

Golestanifar A, Masroor A, Khedri H, Saberiyan M, Nejatizadeh A Clin Exp Med. 2025; 25(1):64.

PMID: 39969652 PMC: 11839865. DOI: 10.1007/s10238-025-01589-z.


Safety of Janus kinase inhibitors in rheumatoid arthritis: a disproportionality analysis using FAERS database from 2012 to 2022.

Mikaeili B, Alqahtani Z, Hincapie A, Guo J Clin Rheumatol. 2025; .

PMID: 39945946 DOI: 10.1007/s10067-025-07360-9.


Occupational dust and chemical exposures and the development of autoimmune rheumatic diseases.

Nikpour M, Morrisroe K, Calderone A, Yates D, Silman A Nat Rev Rheumatol. 2025; 21(3):137-156.

PMID: 39910253 DOI: 10.1038/s41584-024-01216-3.


References
1.
Kvien T, Uhlig T, Odegard S, Heiberg M . Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci. 2006; 1069:212-22. DOI: 10.1196/annals.1351.019. View

2.
Silman A, Ollier W, Holligan S, Birrell F, Adebajo A, Asuzu M . Absence of rheumatoid arthritis in a rural Nigerian population. J Rheumatol. 1993; 20(4):618-22. View

3.
Holoshitz J . The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol. 2010; 22(3):293-8. PMC: 2921962. DOI: 10.1097/BOR.0b013e328336ba63. View

4.
Gabriel S, Michaud K . Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009; 11(3):229. PMC: 2714099. DOI: 10.1186/ar2669. View

5.
Turk J, Zahavi E, Gorman A, Murray K, Turk M, Veale D . Exploring the effect of alcohol on disease activity and outcomes in rheumatoid arthritis through systematic review and meta-analysis. Sci Rep. 2021; 11(1):10474. PMC: 8131728. DOI: 10.1038/s41598-021-89618-1. View